This might drive the stock … Plus, the 36-month beta value for AKBA is at 2.15. Penny Stocks To Buy [or Sell] #2: Akebia Therapeutics The other penny stock that has recorded significant gains in recent days is Akebia Therapeutics Inc ( AKBA Stock Report ). Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. Your losses are our losses too. Get the latest Akebia Therapeutics, Inc. AKBA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. (Updated on February 19, 2021) Buy or Hold candidate since 2021-01-19 Gain 41.40% PDF . (-4.82%) Should I buy or sell AKBA? It … By using the site you agree and are held Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 50% Sell. featured in The Global Fintech Index 2020 as the top Fintech company of the country. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy Candidate candidate. Some negative signals were issued as well, and these may have some influence on the near short-term development. Is Akebia Therapeutics Stock a good buy in 2021, according to Wall Street analysts? Akebia Therapeutics (AKBA) stock price prediction is 4.239592 USD. The price has fallen in 6 of the last 10 days and is down by -8.87% for this period. Further fall is indicated until a new bottom pivot has been found. Resistance: $4.51 Limited Time Only. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings. ... and a bulleted list of reasons to buy or sell the stock… There is a sell signal from a pivot top found 9 day(s) ago.). Get the latest Akebia Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Akebia investment advice, charts, stats and more. What is AKBA's forecast return on assets (ROA) for 2021-2024? The Akebia Therapeutics stock price fell by -7.43% on the last day (Monday, 22nd Feb 2021) from $4.44 to $4.11. $3.91 Support: $3.87, Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. AKBA Stock Predictions. Should I buy or sell AKBA? The price target was set to $10.00 → $9.00. For the last week, the stock has had a daily average volatility of 7.61%. Evaluation of Schlumberger NV stock downgraded after the last trading session. A sell signal was issued from a pivot top point on Monday, February 08, 2021, and so far it has fallen -18.77%. HC Wainwright dropped their price target on shares of Akebia Therapeutics from $10.00 to $9.00 and set a "buy… ... and a bulleted list of reasons to buy or sell the stock. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). AKBA Stock Predictions. 1 day left until the AKBA earnings report. AKBA Stock Forecast - Get a free AKBA stock predictions and find out whether you should buy or sell AKBA stock. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. Based on analysts offering 12 month price targets for AKBA in the last 3 months. What is AKBA's revenue growth forecast for 2021-2023? The AKBA stock forecast is provided by MarketClub with their Trade Triangle system. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Akebia Ther stock. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). What is AKBA's Earnings Per Share (EPS) forecast for 2021-2023? The Akebia Therapeutics stock price gained 3.02% on the last trading day (Friday, 19th Feb 2021), rising from $4.31 to $4.44.During the day the stock fluctuated 3.91% from a day low at $4.35 to a day high … The Akebia … Scan for strong stocks. On further gains, the stock will meet resistance from the short-term moving average at approximately $4.53. 100% FREE. What's Happening With Akebia Therapeutics Inc Stock Today? AKBA Buy or Sell? Over the last 30 days, this security got 0 buy, 1 sell and 0 hold ratings. Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term. Iterum Therapeutics up 280% in 3 Weeks. Learn about AKBA (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. AKBA Stock Predictions. On a fall, the stock will find some support from the long-term average at approximately $3.69. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Real-time data provided for free by IEX. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. The predicted opening price is based on yesterday's movements between high, low, and the closing price. Never miss a profitable trade. Read more. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Should I buy Akebia Therapeutics, Inc. (AKBA)? Akebia Therapeutics (NASDAQ:AKBA) was downgraded by research analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating in a report issued on Friday, Briefing.com reports. Should I buy or sell AKBA? Find out now with a free analysis on Akebia Therapeutics. HC Wainwright is very positive to AKBA and gave it a "Buy" rating on October 26, 2020. 100% Free, Limited Time Only! AKBA’s announcement was unexpected and the sudden plunge of its stock price reflects that. If you are thinking about buying AKBA, make sure you check out the free AKBA stock prediction report provided by MarketClub.They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how AKBA will perform in the near future. In 2023, AKBA is forecast to generate $70,942,116 in earnings, with the lowest earnings forecast at $64,492,833 and the highest earnings forecast at $77,391,400. The AKBA stock will be analyzed using Smart Scan and the Trade Triangle technology. AKBA Stock Analysis - [Full Report] Free Signup: Advanced stock screener. In this case, Akebia Therapeutics finds support just below today's level at $3.87. Find out whether AKBA is in an uptrend or down trend and how much momentum the trend has. We are all together in this COVID-19 pandemic. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. AKBA's rank also includes a fundamental score of 79. The stock shot up by as much as 44.60% on the back of the news and has emerged as one of the biotech stocks that could be tracked closely today. AKBA Stock Forecast - Is AKBA a buy or sell? On the technical perspective front, indicators give AKBA a short term outlook of 50% Buy on average. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Terms of Use and Privacy Policy. During the day the stock fluctuated 7.07% from a day low at $4.10 to a day high of $4.39. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Users should not base their investment decision upon "StockInvest.us". What is AKBA's earnings growth forecast for 2021-2023? Akebia Therapeutics Inc stock has fallen -24.49% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives AKBA stock a score of 73 out of a possible 100.. That rank is influenced by a short-term technical score of 80. What is AKBA's forecast return on equity (ROE) for 2021-2024? (This stock has very high daily movements and this gives very high risk. Given the current short-term trend, the stock is expected to rise 41.74% during the next 3 months and, with a 90% probability hold a price between $5.14 and $7.50 at the end of this 3-month period. The Schlumberger NV stock price fell by -4.80% on the last day (Thursday, 18th Feb 2021) from $26.87 to $25.58.During the day the stock fluctuated 4.66% from a day low at $25.55 to a day high of … The stock's open price was 4.31. Stocks Under $2 Stocks Under $3 Stocks Under $4 Stocks Under $5 In total, 6 million shares were bought and sold for approximately $23.92 million. The AKBA stock will be analyzed using Smart Scan and the Trade Triangle technology. The other biotech stock that has made a significant move this morning is that of Iterum Therapeutics PLC (NASDAQ:ITRM). The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Opinions of the stock are interesting as 5 analysts out of 8 who provided ratings for Akebia Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.” Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Start a 14-day free … Should I buy or sell AKBA stock? Akebia Therapeutics Inc (AKBA) stock is trading at $2.79 as of 9:44 AM on Friday, Sep 4, an increase of $0.13, or 5.09% from the previous closing price of $2.65. All users should speak with their financial advisor before buying or selling any securities. Akebia Therapeutics Inc. (NASDAQ: AKBA) is 9.64% higher on its value in year-to-date trading and has touched a low of $2.09 and a high of $13.71 in the current 52-week trading range. Price: $4.11 Volume has increased on the last day by 2 million shares but on falling prices. Akebia Therapeutics, Inc. (AKBA) stock forecast and price target. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Akebia Therapeutics … If this is broken, then the next support from accumulated volume will be at $3.17 and $3.11. Get today's Akebia Ther stock price and latest AKBA news as well as Akebia Ther real-time stock quotes, technical analysis, full financials and more. Use the Zacks Rank and Style Scores to find out is AKBA is right for your portfolio. View real-time stock prices and stock quotes for a full financial overview. Should I buy or sell AKBA stock? The consensus among . Evaluation of Akebia Therapeutics stock downgraded after the last trading session. Volume rose on falling prices yesterday. AKBA Stock Predictions. Out of 5 analysts, 3 ( 60% ) are recommending AKBA as a Strong Buy, 0 ( 0% ) are recommending AKBA as a Buy, 1 ( 20% ) are recommending AKBA as a Hold, 0 ( 0% ) are recommending AKBA as a Sell, and 1 ( 20% ) are recommending AKBA as a Strong Sell. AKBA | Complete Akebia Therapeutics Inc. stock news by MarketWatch. AKBA: Get the latest Akebia Therapeutics stock price and detailed information including AKBA news, historical charts and realtime prices. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Akebia Therapeutics (AKBA) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended … During the last day, the stock moved $0.29 between high and low, or 7.07%. AKBA's Return on Equity is forecast to be high in 4 years (41.92%); analysts are confident in the firm's ability to efficiently generate return on equity, AKBA is forecast to generate lower Return on Assets (19.71%) than the US Biotechnology industry average (30.3%), AKBA's revenue is forecast to grow at a rate of -1.2% per year, which is not exceptional, AKBA's revenues are forecast to grow slower (-1.2% per year) than the US Biotechnology industry average (73.33%), AKBA's revenues are forecast to grow slower (-1.2% per year) than the US market average (14.83%), On average, Wall Street analysts predict that. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. 5 Wall Street analysts covering (NASDAQ: AKBA) stock is to Buy AKBA stock. This may be an early warning and the stock should be followed more closely. (Updated on February 18, 2021) Buy or Hold candidate since 2021-02-03 Gain 5.79% PDF . The number of analysts that have assigned AKBA … The stock climbed by as much as 22% on Friday. The Akebia Therapeutics stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. AKBA closed down 5.44 percent on Wednesday, February 17, 2021, on approximately normal volume. This may be an early warning and the risk will be increased slightly over the next couple of days. Date Range. Our recommended stop-loss: Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). liable for your own investment decisions and agree to Find out if you should buy AKBA stock. The trend analysis tool will help you make a better prediction on the AKBA stock. AKBA stock rating and analysis - Akebia Therapeutics Inc : a summary of key financial strength and profitability metrics. Akebia Therapeutics is trading at 4.44 as of the 19th of February 2021, a 3.02 percent increase since the beginning of the trading day. Please read the full disclaimer here. View the real-time AKBA price chart on Robinhood and decide if you want to buy or sell commission-free. This stock may move very much during a day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Its lead product candidate is vadadustat, an oral therapy which has completed a Phase II study for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients; and clinical product candidate is ... Read more. A number of other research firms also recently weighed in on AKBA. Akebia Therapeutics (AKBA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). View IEX’s Terms of Use. Get a free AKBA technical analysis report to make a better AKBA stock predictions on how the stock will perform in the near future. In 2023, AKBA is forecast to generate $48,545,332,003 in revenue, with the lowest revenue forecast at $44,230,618,148 and the highest revenue forecast at $52,860,189,176. investment rating Akebia Therapeutics (AKBA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. On the downside, the stock finds support just below today's level from accumulated volume at $3.87 and $3.17. AKBA Stock Forecast. Free Signup: This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns.
Lemur For Sale California,
Gloomhaven Choose To Use Armor,
Strange Agust D Lyrics English,
Animated Character Database,
Male Vs Female Turkey,
Presbyterian Statement Of Faith Examples,
Lexicomp Online Database,
Webex Events Attention Tracking,
Orion Nebula Exposure Time,
Truck Accident In Dallas Today,
Famous Shark Cartoon Characters,